Literature DB >> 10502304

Effects of hyperthermia on the cytoskeleton and focal adhesion proteins in a human thyroid carcinoma cell line.

S H Huang1, K J Yang, J C Wu, K J Chang, S M Wang.   

Abstract

Hyperthermia is reported to act as a sensitizer to chemotherapeutic drugs in the treatment of cancer. Thyroid follicular carcinoma were used to elucidate the effects of hyperthermic treatment (41-43 degrees C) on cell morphology, cytoskeleton, and the focal adhesion complex. The critical temperature that resulted in inhibition of cell proliferation as the cell number in the same area did not increase over a 23 h time course and irreversible changes in cell morphology was 42-43 degrees C. An immunofluorescence study on heat-treated cells (43 degrees C, 1-5 h) demonstrated that depolymerization of actin filaments, intermediate filaments, and microtubules accounted for the rounding-up of cells and detachment from the substratum. Characteristic staining patterns for integrin alphav, focal adhesion kinase, and vinculin were noted in untreated cells, but the immunoreactive intensities for these proteins became weaker with time of heat treatment. Anti-phosphotyrosine staining revealed less immunoreactivity in the focal adhesions in treated cells compared with control cells. The disappearance of integrin alphav from the cell surface may result in inhibition of integrin-mediated activation of focal adhesion kinase, which results in dephosphorylation of focal adhesion components and its disassembly. These results indicate that hyperthermia induces disruption of integrin-mediated actin cytoskeleton assembly and, possibly, of other integrin-mediated signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502304

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Trask phosphorylation defines the reverse mode of a phosphotyrosine signaling switch that underlies cell anchorage state.

Authors:  Danislav S Spassov; Ching H Wong; Mark M Moasser
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

2.  Single cell viability and impact of heating by laser absorption.

Authors:  Franziska Wetzel; Susanne Rönicke; Karla Müller; Markus Gyger; Daniel Rose; Mareike Zink; Josef Käs
Journal:  Eur Biophys J       Date:  2011-06-18       Impact factor: 1.733

3.  Investigating biomechanical noise in neuroblastoma cells using the quartz crystal microbalance.

Authors:  Abhinav Prasad; Anna Huefner; Sumeet Mahajan; Ashwin A Seshia
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

4.  Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids.

Authors:  Lisi Zeng; Quanxing Liao; Quanxing Zhao; Shengwei Jiang; Xianzi Yang; Hongsheng Tang; Qingjun He; Xiansheng Yang; Shuxian Fang; Jinfu He; Weiwen Cui; Laiqiang Huang; Shaohua Ma; Shuzhong Cui
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

Review 5.  A Comprehensive Review of Optical Stretcher for Cell Mechanical Characterization at Single-Cell Level.

Authors:  Tie Yang; Francesca Bragheri; Paolo Minzioni
Journal:  Micromachines (Basel)       Date:  2016-05-13       Impact factor: 2.891

6.  Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells.

Authors:  Chueh-Hsuan Lu; Wei-Ting Chen; Chih-Hsiung Hsieh; Yu-Yi Kuo; Chih-Yu Chao
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

7.  Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles.

Authors:  Antonio Cervadoro; Chiara Giverso; Rohit Pande; Subhasis Sarangi; Luigi Preziosi; Jarek Wosik; Audrius Brazdeikis; Paolo Decuzzi
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 8.  Magnetic Hyperthermia and Radiation Therapy: Radiobiological Principles and Current Practice .

Authors:  Spiridon V Spirou; Martina Basini; Alessandro Lascialfari; Claudio Sangregorio; Claudia Innocenti
Journal:  Nanomaterials (Basel)       Date:  2018-06-03       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.